Apolipoprotein E ε4 and impaired episodic memory in community-dwelling elderly people: A marked sex difference. The Hordaland Health Study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 8, 2006, Pages 902-908

  Lehmann, D J ^a   Refsum, H ^a,b,c   Nurk, E ^a,b   Warden, D R ^a   Tell, G S ^c   Vollset, S E ^c   Engedal, K ^d   Nygaard, H A ^c   Smith, A D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; COMMUNITY LIVING; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MEMORY DISORDER; NORWAY; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; ZYGOSITY; ALLELE; COHORT ANALYSIS; GENETICS; GENOTYPE; PERIODICITY; RISK;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION DISORDERS; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MEMORY DISORDERS; ODDS RATIO; PERIODICITY; SEX FACTORS;

EID: 33746282189     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.077818     Document Type: Article

References (41)

1. Ohm TG, Müller H, Braak H, et al. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 1995;64:209-17.
2. Helkala EL, Koivisto K, Hanninen T, et al. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci Lett 1996;204:177-80.
3. Hyman BT, Gomez-Isla T, Briggs M, et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 1996;40:55-66.
4. Mayeux R, Small SA, Tang M, et al. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. Neurobiol Aging 2001;22:683-9.
5. Wilson RS, Schneider JA, Barnes LL, et al. The apolipoprotein E ε4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol 2002;59:1154-60.
6. Deary U, Whiteman MC, Pattie A, et al. Apolipoprotein E gene variability and cognitive functions at age 79: a follow-up of the Scottish mental survey of 1932. Psychol Aging 2004;19:367-71.
7. Kang JH, Logroscino G, De Vivo I, et al. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging 2005;26:475-84.
8. Feskens EJM, Havekes LM, Kalmijn S, et al. Apolipoprotein ε4 allele and cognitive decline in elderly men. BMJ 1994;309:1202-6.
9. Herr C, Dufouil C, Brousseau T, et al. Early effect of ApoE-ε4 allele on cognitive results in a group of highly performing subjects: the EVA study. Neurosci Lett 1996;218:9-12.
10. Yaffe K, Cauley J, Sands L, et al. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arch Neurol 1997;54:111-4.
11. Kuller LH, Shemanski L, Manolio T, et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke 1998;29:388-98.
12. Fillenbaum GG, Landerman LR, Blazer DG, et al. The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. J Am Geriatr Soc 2001;49:1148-55.
13. Tilvis RS, Kahonen-Vare MH, Jolkkonen J, et al. Predictors of cognitive decline and mortality of aged people over a 10 year period. J Geronlol A Biol Sci Med Sci 2004;59:268-74.
14. Shadlen M-F, Larson EB, Wang L, et al. Education modifies the effect of apolipoprotein epsilon 4 on cognitive decline. Neurobiol Aging 2005;26:17-24.
15. Small BJ, Rosnick CB, Fratiglione L, et al. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004;19:592-600.
16. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
17. Yasuda M, Maeda K, Shimada K, et al. Apolipoprotein E ε4 allele and gender difference in risk of Alzheimer's disease. Alzheimer's Res 1995;1:77-81.
18. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996;58:803-11.
19. Farrer LA, Cupples LA, van Duijn CM, et al. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol 1995;38:797-808.
20. Farrer IA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278:1349-56.
21. Fleisher A, Grundman M, Jack CRJ, et al. Sex, apolipoprotein E E ε4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol 2005;62:953-7.
22. Mortensen EL, Høgh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 2001;57:89-95.
23. Bookman I, Jones S, Berger AK, et al. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 2005;19:520-31.
24. Aggarwal NT, Wilson RS, Beck TL, et al. Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005;76:1479-84.
25. Nurk E, Refsum H, Tell GS, et al. Plasma total homocysteine and memory in the elderly. The Hordaland Homocysteine Study. Ann Neurol 2005;58:847-57.
26. Nygård O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526-33.
27. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-9.
28. Kendrick LK, Gibson AJ, Moyes ICA. The revised Kendrick battery: clinical studies. Br J Soc Clin Psychol 1979;18:329-40.
29. Engedal K, Haugen PK, Gilje K, et al. Efficacy of short mental tests in the detection of mental impairment in old age. Compr Gerontol 1988;2:87-93.
30. des Rosiers G, Hodges JR, Berrios G. The neuropsychological differentiation of patients with very mild Alzheimer's disease and/or major depression. J Am Geriatr Soc 1995;43:1256-63.
31. Refsum H, Nygard O, Kvale G, et al. The Hordaland Homocysteine Study: the opposite tails odds ratios reveal differential effects of gender and intake of vitamin supplements at high and low plasma total homocysteine concentrations. J Nutr 1996;126:1244S-1248S.
32. Nygard O, Refsum H, Ueland PM, et al. Coffee consumption and plasma total homocysteine: the Hordaland Homocysteine Study. Am J Clin Nutr 1997;65:136-43.
33. Bäckman L, Small BJ, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain 2001;124:96-102.
34. Elias MF, Beiser A, Wolf PA, et al. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort. Arch Neurol 2000;57:808-13.
35. Smith GE, Bohac DL, Waring SC, et al. Apolipoprotein E genotype influences cognitive 'phenolype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998;50:355-62.
36. Small BJ, Graves AB, McEvoy CL, et al. Is APOE-ε4 a risk factor for cognitive impairment in normal aging? Neurology 2000;54:2082-8.
37. Kim KW, Youn JC, Jhoo JH, et al. Apolipoprotein E ε4 allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals. Int J Geriatr Psychiatry 2002;17:635-40.
38. Kumar T, Liestol K, Maehlen J, et al. Allele frequencies of apolipoprotein E gene polymorphisms in the protein coding region and promoter region (-491A/T) in a healthy Norwegian population. Hum Biol 2002;74:137-42.
39. Haan MN, Shemanski L, Jagust WJ, et al. The role of APOE ε4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999;282:40-6.
40. Flory JD, Manuck SB, Ferrell RE, et al. Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am J Med Genet 2000;96:707-11.
41. Deary U, Whiteman MC, Pattie A, et al. Cognitive change and the APOE ε4 allele. Nature 2002;418:932.